PE130999A1 - 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba - Google Patents

4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba

Info

Publication number
PE130999A1
PE130999A1 PE1998001100A PE00110098A PE130999A1 PE 130999 A1 PE130999 A1 PE 130999A1 PE 1998001100 A PE1998001100 A PE 1998001100A PE 00110098 A PE00110098 A PE 00110098A PE 130999 A1 PE130999 A1 PE 130999A1
Authority
PE
Peru
Prior art keywords
alkyl
naftiridin
oxo
cycloalkyl
leaguards
Prior art date
Application number
PE1998001100A
Other languages
English (en)
Spanish (es)
Inventor
Pamela Albaugh
Robert W Desimone
Gang Liu
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of PE130999A1 publication Critical patent/PE130999A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PE1998001100A 1997-08-25 1998-11-13 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba PE130999A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91818097A 1997-08-25 1997-08-25

Publications (1)

Publication Number Publication Date
PE130999A1 true PE130999A1 (es) 1999-12-16

Family

ID=25439933

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998001100A PE130999A1 (es) 1997-08-25 1998-11-13 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba

Country Status (24)

Country Link
EP (1) EP1007526A1 (no)
JP (1) JP2001514181A (no)
KR (1) KR20010023313A (no)
CN (1) CN1268136A (no)
AP (1) AP2000001742A0 (no)
AU (1) AU753800B2 (no)
BG (1) BG104192A (no)
BR (1) BR9811362A (no)
CA (1) CA2301599C (no)
EG (1) EG21717A (no)
HU (1) HUP0003258A3 (no)
IL (1) IL134291A0 (no)
IS (1) IS5382A (no)
LV (1) LV12539B (no)
NO (1) NO20000822L (no)
NZ (1) NZ502548A (no)
OA (1) OA11293A (no)
PE (1) PE130999A1 (no)
PL (1) PL338783A1 (no)
SI (1) SI20270A (no)
SK (1) SK2162000A3 (no)
TW (1) TW574221B (no)
WO (1) WO1999010347A1 (no)
YU (1) YU10500A (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4818000A (en) * 1999-05-06 2000-11-21 Neurogen Corporation Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
WO2000071528A1 (en) * 1999-05-25 2000-11-30 Neurogen Corporation 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands
US6562822B2 (en) 2000-07-12 2003-05-13 Pharmacia & Upjohn Company Heterocyle carboxamides as antiviral agents
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
US6730682B2 (en) 2000-07-12 2004-05-04 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
ES2287170T3 (es) 2000-10-12 2007-12-16 MERCK & CO., INC. Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa.
CA2425625A1 (en) 2000-10-12 2002-07-18 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
DE60138635D1 (de) 2000-10-12 2009-06-18 Merck & Co Inc Aza- und polyaza naphthalenyl karboxamide als inhibitoren der hiv-integrase
US20020151591A1 (en) * 2000-10-17 2002-10-17 Anabella Villalobos Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders
SK10752003A3 (sk) * 2001-03-01 2004-08-03 Pfizer Products Inc. Použitie inverzných agonistov GABAA v kombinácii s parciálnymi agonistami receptora nikotínu, estrogénom, selektívnymi modulátormi estrogénu alebo vitamínom E pri liečení kognitívnych porúch
AR036256A1 (es) 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
DE60315796T2 (de) 2002-01-17 2008-06-05 Merck & Co., Inc. Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen
JP4494020B2 (ja) 2002-03-15 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション Ｈｉｖインテグラーゼ阻害剤として有用なｎ−（置換ベンジル）−８−ヒドロキシ−１，６−ナフチリジン−７−カルボキサミド
WO2004106336A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides
WO2004106334A2 (en) * 2003-05-28 2004-12-09 Pfizer Products Inc. Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation
EP2540722B1 (en) * 2006-10-16 2016-06-08 Bionomics Limited Novel anxiolytic compounds
EP2578216A1 (en) * 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR204162A1 (es) * 1972-05-08 1975-11-28 Yamanouchi Pharma Co Ltd Proceso para la preparacion de derivados de ampicilina
GB1433774A (en) * 1973-02-26 1976-04-28 Allen & Hanburys Ltd Heterocyclic compounds apparatus for conveying articles
US4374138A (en) * 1981-11-13 1983-02-15 Warner-Lambert Company Antibacterial amide compounds, compositions, and methods of use
DD295360A5 (de) * 1987-07-03 1991-10-31 Akad Wissenschaften Verfahren zur Herstellung von aktivierten Carbonsäureestern
DD279875A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von aktivierten carbonsaeureestern
DD279887A1 (de) * 1987-07-03 1990-06-20 Inst Pharmakologische Forschun Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika
JPS6461461A (en) * 1987-09-01 1989-03-08 Otsuka Pharma Co Ltd Benzohetero ring derivative

Also Published As

Publication number Publication date
NO20000822L (no) 2000-04-13
EP1007526A1 (en) 2000-06-14
AU753800B2 (en) 2002-10-31
PL338783A1 (en) 2000-11-20
BR9811362A (pt) 2000-08-22
YU10500A (sh) 2002-10-18
JP2001514181A (ja) 2001-09-11
LV12539A (en) 2000-10-20
AP2000001742A0 (en) 2000-02-24
NO20000822D0 (no) 2000-02-18
WO1999010347A1 (en) 1999-03-04
IL134291A0 (en) 2001-04-30
BG104192A (en) 2001-05-31
LV12539B (en) 2001-01-20
SI20270A (sl) 2000-12-31
CA2301599C (en) 2003-03-25
SK2162000A3 (en) 2001-03-12
CA2301599A1 (en) 1999-03-04
KR20010023313A (ko) 2001-03-26
HUP0003258A2 (en) 2001-03-28
IS5382A (is) 2000-02-22
TW574221B (en) 2004-02-01
CN1268136A (zh) 2000-09-27
NZ502548A (en) 2002-06-28
HUP0003258A3 (en) 2001-05-28
AU9117398A (en) 1999-03-16
OA11293A (en) 2002-11-19
EG21717A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
PE130999A1 (es) 4-oxo-naftiridin-3-carboxamidas sustituidas; ligandos de receptor cerebral gaba
DE69223989T2 (de) Azyklische ethylendiaminderivate als 'substance p rezeptor' antagonisten
PE91798A1 (es) Pirrolicarboxanilidas condensadas: utiles como ligandos receptores
TNSN97158A1 (fr) Certains pyrrolecarboxanilide fondus ; une nouvelle classe de ligands recepteurs du cerveau (acide gamma -aminobutyrique).
PE20021094A1 (es) Derivados de ciclohexano-1,4-diamina sustituidos
PE20040583A1 (es) Nuevos derivados de benzimidazol
PE20000013A1 (es) Derivados de adenosina
DE69331190D1 (de) Überbrückte azabicyclische derivate als substanz p antagonisten
AR062299A1 (es) Derivados de bencimidazol
CO5031253A1 (es) Antagonistas receptores y5 de neuropeptidos composiciones farmaceuticas que las contienen
MX9702601A (es) AGONISTAS beta-ADRENERGICOS HETEROCICLICOS.
PE46899A1 (es) Derivados de n-fenil-sulfonamida
RU2005104434A (ru) Производные 1-гетероциклилалкил-3-сульфонилиндола или - индазола как лиганды 5-гидрокситриптамина-6
PE20020917A1 (es) Derivados de imidazol como bloqueadores del receptor n-metil-d-aspartato
ES2059327T3 (es) Derivados de tetrahidronaftaleno y de indano, obtencion de los mismos y utilizacion en preparados farmaceuticos.
NO940927D0 (no) Kondenserte tricykliske nitrogenholdige heterocykler som substans-P-reseptor-antagonister
DE60232029D1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid-derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
PE20021067A1 (es) Empleo de antagonistas del receptor nk3
PE20060457A1 (es) Derivados de difenil eter como antagonistas de los receptores 5ht2
ATE247639T1 (de) Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden
PE20030718A1 (es) Lactamas como antagonistas de taquiquininas
ES2130135T3 (es) Nuevos compuestos heterociclicos de 6,7,8,9-tetrahidro-3h-benz(e)indol con actividad terapeutica sobre el sistema nervioso central.
RU2006105782A (ru) Производные 1-сульфонилиндола, их получение и их применение в качестве лигандов 5-нт-6
HUP0001165A2 (hu) NK1 és NK2 antagonista hatású acil-amino-alkil-amid-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra
DE69912419D1 (de) Phenylsulfonamid-phenylethylamine nützlich als dopamin-rezeptoren

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed